Skip to main content
Eurosurveillance logoLink to Eurosurveillance
. 2022 Aug 18;27(33):2200603. doi: 10.2807/1560-7917.ES.2022.27.33.2200603

Monkeypox self-diagnosis abilities, determinants of vaccination and self-isolation intention after diagnosis among MSM, the Netherlands, July 2022

Haoyi Wang 1, Kennedy JI d'Abreu de Paulo 1, Thomas Gültzow 1, Hanne ML Zimmermann 1, Kai J Jonas 1
PMCID: PMC9389856  PMID: 35983772

Abstract

Monkeypox is a zoonotic disease and leads to a smallpox-like disease in humans. The current epidemic in European countries requires informed responses. We investigated the ability to self-diagnose a potential infection, and determinants of vaccination and self-isolation intention after diagnosis among 394 MSM in the Netherlands. We found that about half were able to self-diagnose monkeypox, that 70% had a high intention to get vaccinated and 44% to self-isolate after monkeypox diagnosis. Determinants went beyond mere risk behaviour criteria.

Keywords: Monkeypox, Vaccination, MSM, Prevention, Self-diagnosis, Isolation


The global epidemic of monkeypox, a zoonotic disease, has recently changed from infections predominantly following an interaction with animals, to human-to-human transmission [1,2]. The monkeypox epidemic in European countries is currently predominantly affecting men-who-have-sex-with-men (MSM) and the number of infections is still increasing [3,4]. In the Netherlands 1,025 cases have been reported as at 11 August 2022, the majority in Amsterdam. Given the spread of the disease, investigating self-diagnostic abilities, and vaccination and self-isolation intentions is relevant to tailor further public health responses.

Survey and participants

We conducted an online survey among MSM using a cohort established in 2017 [5] (n = 257), along with recruitment of MSM on a gay online dating app (n = 137) in the first half of July 2022, before the start of targeted monkeypox vaccination in the Netherlands [6]. Of the included 394 MSM, 43% (n=171) were below the age of 45-years, 6% (n=22) were living with HIV and 66% (n=241) were currently using HIV pre-exposure prophylaxis (PrEP) (see supplementary materials S1 for the population characteristics by PrEP use status, and S2 for participants’ age distribution).

Monkeypox self-diagnosis

We provided participants with four images and asked them to indicate what condition this could be. All of the images were showing lesions in parts of the face, one depicted a monkeypox lesion, the other three a vesicle due to a staphylococcal skin infection, a syphilis stage-2, and eczema. Only the image of eczema was diagnosed predominantly correct (67%), monkeypox lesion and staphylococcal infection images triggered some correct hits, but also considerable amounts of false self-diagnoses (up to 48% and 58%, respectively, for all alternative diagnoses combined), syphilis stage-2 was most frequently misdiagnosed as monkeypox (52%) (Table 1).

Table 1. Ability to self-diagnose a monkeypox lesion among MSM, the Netherlands July 2022 (n=394).

Displayed on image Self-diagnosis
Monkeypox Staphylococcus Syphilis Eczema
n % n % n % n %
Monkeypox 206 52.3 150 38.1 30 7.6 8 2.0
Staphylococcal skin infection 94 23.9 167 42.4 105 26.6 28 7.1
Syphilis stage-2 204 51.8 91 23.1 91 23.1 8 2.0
Eczema 14 3.6 98 24.9 20 5.1 262 66.5

Vaccination and self-isolation intentions

Vaccination intention and self-isolation intention were measured on a 1─5 Likert scale (with 1=“Very low” and 5=“Very high”). In this study, we categorised these two endpoints as “High/very high (scale 4 and 5)” and “The rest of the scale” for the modelling analysis. Overall, 70% of participants showed high vaccination intention and 44% showed high intention for self-isolation after diagnosis i.e. until all lesions are gone, usually for up to 21 days [7]. Given that currently monkeypox vaccinations are administered to PrEP-using MSM in the Netherlands [8], we adjusted for PrEP use status (current users (n = 241) vs PrEP-naïve MSM or PrEP-discontinued MSM (n = 122)) to compare the standardised prevalence ratio (SPR). We found that despite of the higher prevalence among PrEP users in both vaccination intention and self-isolation intention, the adjusted SPRs showed no significant differences, indicating similar vaccination and self-isolation intentions among PrEP users and non-PrEP-users (Table 2).

Table 2. Prevalence and standardised prevalence ratio of monkeypox vaccination and self-isolation intention, the Netherlands, July 2022 (n=394).

Sub-population Vaccination intention
(Extremely likely vs rest of scale)a
Monkeypox self-isolation intention
(Extremely likely vs rest of scale)a
Prevalence 95%CI SPRb 95%CI Prevalence 95%CI SPRb 95%CI
n % n %
PrEP users 178 73.86 67.97–79.00 1.01 0.87–1.17 105 43.57 37.45–49.81 1.06 0.87–1.28
Non-PrEP users 87 71.31 62.73–78.59 0.97 0.78–1.19 43 35.25 27.34–33.06 0.86 0.63–1.14
Total sample 276 70.01 65.35–74.36 NA NA 173 43.91 39.09–48.84 NA NA

CI: confidence interval; NA: not applicable; PrEP: pre-exposure prophylaxis; SPR: standardised prevalence ratio.

a 1−5 Likert scale, with 1 = extremely unlikely and 5 = extremely likely)

b Adjusted for PrEP use status.

Determinants predicting vaccination and self-isolation intention

To identify vaccination intention differences and among MSM sub-populations and which sub-population may follow the current self-isolation policy best, we conducted two multivariable logistic regression analyses with socio-demographic, behavioural, and psychosocial determinants. First, we conducted univariable logistic modelling with each of the selected determinants to investigate potential correlations with being extremely likely to get vaccinated. We retained all determinants with p < 0.10 in the univariable analysis with the full variance in the multivariable model, given the relatively small sample size (Table 3) (supplementary materials S3 shows the analysis for collinearity). In a sensitivity analysis, we combined somewhat- and extremely-likely intentions to define high intention to explore the implications on the endpoint selection (sensitivity analysis results are shown in the supplementary materials S4).

Table 3. Determinants of monkeypox vaccination intention and self-isolation intention, the Netherlands, July 2022 (n=394).

Variables Vaccination intention (extremely likely vs rest of scale) Self-isolation intention (extremely likely vs rest of scale)
Univariable model Multivariable model Univariable model Multivariable model
OR 95%CI p value aOR 95%CI p value OR 95%CI p value aOR 95%CI p value
Socio-demographic determinants
Age
< 45 years Ref. NA Ref. Ref.
> 45 years 1.04 0.67─1.61 0.861 1.41 0.94─2.11 0.098 1.11 0.70─1.77 0.663
Relationship
Single Ref. Ref. Ref. Ref.
Single but dating 1.98 1.06─3.73 0.033 2.42 1.13─5.20 0.024 1.84 0.99─3.41 0.052 1.57 0.82─3.03 0.177
Monogamous relationship 0.79 0.36─1.75 0.564 1.25 0.45─3.51 0.671 0.79 0.34─1.85 0.586 0.70 0.28─1.72 0.434
Open/polyamorous relationship 3.44 1.94─6.08 < 0.001 3.96 1.97─7.99 0.001 1.44 0.84─2.47 0.186 1.20 0.67─2.17 0.536
Education
Lower than bachelor Ref. NA Ref. Ref.
Bachelor 0.94 0.53─1.67 0.832 0.51 0.30─0.89 0.017 0.54 0.30─0.95 0.034
Master 1.17 0.66─2.08 0.593 0.49 0.29─0.84 0.009 0.52 0.29─0.93 0.029
PhD or higher 1.91 0.71─5.18 0.202 0.73 0.32─1.66 0.454 0.83 0.34─2.56 0.676
Employment
Employed Ref. Ref. Ref. Ref.
Unemployed or receiving social welfare 0.84 0.53─1.67 0.733 0.99 0.29─3.48 0.991 2.01 0.75─5.42 0.166 1.77 0.63─4.93 0.274
Retired 9.58 0.66─2.08 0.028 11.04 1.35─90.36 0.025 4.79 1.73─13.30 0.003 5.35 1.84─15.57 0.002
Student 1.06 0.71─5.18 0.899 1.32 0.44─3.99 0.613 0.76 0.30─1.95 0.566 0.94 0.34─2.56 0.901
Migration status
Not applicable Ref. NA Ref. Ref.
First-generation migrant 0.83 0.44─1.55 0.552 1.74 0.96─3.14 0.069 1.82 0.97─3.45 0.064
Second-generation migrant 0.90 0.31─2.69 0.863 2.38 0.84─6.69 0.101 2.59 0.84─8.00 0.098
Residence
The rest of the country Ref. NA Ref. NA
Randstad (main urban area) 1.34 0.87─2.08 0.186 0.79 0.53─1.19 0.263
Behavioural determinants
Number of sex partners in the previous 6 months
None Ref. Ref. Ref. NA
1 2.36 0.50─11.12 0.275 1.70 0.23─12.63 0.603 0.71 0.15─3.35 0.669
2─6 3.33 0.76─14.48 0.108 1.62 0.24─1099 0.617 0.45 0.10─1.94 0.283
7─15 5.21 1.16─23.42 0.031 2.26 0.32─16.25 0.415 0.35 0.08─1.59 0.176
More than 15 6.37 1.38─29.36 0.018 2.02 0.26─15.39 0.499 0.52 0.12─2.31 0.389
HIV status
HIV-negative Ref. NA Ref. NA
HIV-positive 1.11 0.42─2.93 0.826 1.31 0.55─3.10 0.536
HIV status unknown or not disclosed 0.33 0.08─1.27 0.107 1.64 0.43─6.21 0.466
PrEP use status
Current PrEP user Ref. Ref. Ref. NA
PrEP naïve or PrEP discontinued 0.66 0.41─1.06 0.0872 0.78 0.41─1.49 0.447 0.79 0.50─1.22 0.286
Any type of substance use in the previous 6 months
Never Ref. NA Ref. NA
Ever 0.60 0.32─1.14 0.121 1.39 0.74─2.58 0.302
Recreational drugs use in the previous 6 months a
Never Ref. NA Ref. NA
Ever 1.39 0.88─2.19 0.163 0.95 0.63─1.43 0.7957
Chemsex in the previous 6 months b
Never Ref. NA Ref. NA
Ever 0.90 0.55─1.46 0.659 0.88 0.56─1.39 0.585
Poppers use in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.35 0.88─2.08 0.173 1.10 0.73─1.64 0.632
Erectile dysfunction medication use in the previous 6 months c
Never Ref. Ref. Ref. NA
Ever 1.48 0.95─2.30 0.087 0.77 0.43─1.39 0.380 1.35 0.90─2.02 0.144
Alcohol use in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.08 0.65─1.77 0.766 0.79 0.49─1.26 0.320
Visited a gay sauna in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.44 0.91─2.28 0.119 1,01 0.66─152 0.965
Visited a darkroom in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.34 0.86─2.10 0.199 1.32 0.88─1.98 0.178
Visited a circuit party in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.01 0.63─1.64 0.952 1.24 0.80─1.93 0.337
Visited a pride event in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.17 0.76─1.80 0.481 1.01 0.68─1.50 0.978
Visited a gay dance club in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.05 0.67─1.65 0.823 1.05 0.69─1.60 0.806
Attended private sex parties in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.20 0.74─1.93 0.464 1.20 0.77─1.85 0.421
Visited fetish events/fairs in the previous 6 months
Never Ref. NA Ref. NA
Ever 1.06 0.62─1.78 0.840 1.21 0.75─1.96 0.427
Psychosocial determinants
Knowing anybody who has/had monkeypox
No Ref. Ref. Ref. NA
Yes 2.87 1.41─5.84 0.003 2.33 0.98─5.52 0.055 1.17 0.69─1.97 0.565
Concern about being infected by monkeypoxd 1.74 1.40─2.16 < 0.001 1.74 1.35─2.26 < 0.001 1.10 0.94─1.30 0.236
Perceived risk of being infected by monkeypoxd 1.73 1.40─2.13 < 0.001 1.21 0.88─1.64 0.237 1.13 0.94─1.36 0.190
Perceived problematic consequences of monkeypoxd 1.21 0.98─1.50 0.075 1.18 0.90─1.53 0.224 1.35 1.09─1.66 0.005 1.39 1.11─1.74 0.005

aOR: adjusted odds ratio; CI: confidence interval; GHB: gamma-hydroxybutyric acid; MDMA: 3,4-methylenedioxymethamphetamine; NA: not applicable; OR: odds ratio; PrEP: pre-exposure prophylaxis; THC: tetrahydrocannabinol.

a I use substances recreationally (for example THC, MDMA, ecstasy, etc).

b I use substances in the context of sex (for example crystal methamphetamine/tina, GHB, ketamine etc.).

c I use erectile dysfunction medication (for example Viagra, Kamagra).

d indicates variable with a 1−5 Likert scale, with 1 = extremely unlikely and 5 = extremely likely)

For vaccination intention as endpoint, among socio-demographic determinants, MSM who were single but dating (adjusted OR (aOR) = 2.42), who had an open/polyamorous relationship (aOR = 3.96) and who were retired (aOR = 11.04) were more likely to have high vaccination intentions. No behavioural determinants were found to be statistically associated. Among psycho-social determinants, we found that knowing someone who has/had monkeypox (aOR = 2.33) and being worried about a monkeypox infection (aOR = 1.74) was associated with high vaccination intention.

For self-isolation intention as endpoint, almost all included socio-demographic determinants showed relevant associations. MSM with bachelor (aOR = 0.54) and master (aOR = 0.52) degrees were less likely to self-isolate after diagnosis for 21 days. Those who were retired (aOR = 5.35) showed higher intentions on the other hand. Similar to the vaccination intention, no behavioural determinant was found to be associated with high self-isolation intentions. Among psychosocial determinants, MSM who perceived more problematic consequences because of a monkeypox infection (aOR = 1.39) were more likely to self-isolate.

Discussion

Given the incubation period of 9 days in the case of exposure via mucous membranes (e.g., anus, mouth, urethra) [9], it is important to detect monkeypox infections quickly to limit onward transmission, which highlights the importance of affected individuals’ ability to detect the typical lesions early on. The findings from a survey including 394 MSM in the Netherlands showed that only about half of them were able to self-diagnose monkeypox from other skin lesions which shows that self-diagnosis in particular of novel diseases, can be challenging. Furthermore, infected individuals should isolate for up to 21 days until all symptoms are gone [4]. Especially after all coronavirus disease (COVID-19)-related quarantine measures, there are limited data available on the acceptance of such measures for other diseases, such as monkeypox. Our results showed that only 44% intended to fully self-isolate after receiving a monkeypox diagnosis.

At the same time, vaccination programs have commenced in many countries that focus on high-risk populations, for example MSM who are using PrEP [8]. Our results revealed that 70% belonging to this group had a high intention to get vaccinated. Given vaccine scarcity [10], it is paramount to identify the populations with the highest risk, but also to gauge general vaccination intention in moderate at-risk populations.

Our main findings hold relevant implications to guide national response to the monkeypox outbreak. Firstly, both the ability to self-diagnose and intention to self-isolate were relatively low among our study participants. Public health and social measures are considered essential [11] to reduce transmission of pathogens with epidemic potential. Thus, health education campaigns/interventions should not only aim to increase vaccination intentions, but also to support concerned individuals in following other mitigation measures such as isolation. Secondly, although close contact during sexual activities is the most frequently suspected route of infection [12] and the main reason to prioritise MSM using PrEP for vaccination in the Netherlands since 25 July 2022 [6], high intention to get vaccinated and self-isolate in this study were not predicted by any of the sexual risk behaviours. This is of note, as the current public communication and vaccination strategy in the Netherlands focuses on motivating those showing higher sexual risk behaviours, while in our study socio-demographic (e.g., education level and migration status) and psycho-social variables (e.g., “knowing someone that has/had monkeypox” and “higher concern about getting infected by monkeypox”) were found predictive for a higher vaccination and self-isolation intention. Our results could inform campaign content and dissemination planning of respective monkeypox prevention campaigns. They suggest it is crucial to increase our efforts to also reach highly educated with these messages, as well as to present realistic stories of monkeypox infections using peer-communication without inducing fear. Even though our findings and other research imply that under certain conditions having fear could increase intention to vaccinate and self-isolate [13].

Also, since vaccination intentions did not differ between PrEP users and non-PrEP-users and non-PrEP-users may also have risk behaviours, prioritising PrEP users may not be sufficient to reach the full potential of the vaccination. Finally, albeit most Dutch monkeypox cases have been reported from Amsterdam, our analysis of geographic differences did not yield significant results.

However, our study is not devoid of limitations. As our analyses were conducted based on MSM from an existing cohort which aimed to investigate PrEP use [9] and MSM who were on an online gay dating app, both groups of participants may be more familiar with new media and rapid access to information sources, and thus may be more likely to have more knowledge about the monkeypox epidemic compared with the general MSM population living in the Netherlands. This may result in overestimated parameters. Additionally, PrEP use may be overrepresented among our participants compared with the general MSM population given the sampling strategy and hence our results may be limited to this population. Yet at the same time, PrEP users are the target group for monkeypox vaccinations in the Netherlands at the moment. Thus, we believe that our sample is capturing relevant parts of the at-risk population. Furthermore, we assessed the concern of getting a monkeypox infection, but did not investigate its determinants further. We believe that future research should investigate preventions intentions, for example, those that reflect changes in vaccine availability, and complement the emerging picture on attitudes related to monkeypox, such as determinants of infection concerns, and also triangulate results obtained among MSM with healthcare provider perspectives. Data from other contexts, for example Italy, show that healthcare providers currently lack relevant knowledge, underestimate the epidemic and the need for tailored responses [14].

Conclusions

To conclude, based on our findings public health policy makers and services should in addition to focussing on vaccinations in their communication, aim to increase MSM’s intentions to self-isolate and their ability to accurately self-diagnose. Efforts should also be stepped up to target MSM at the highest risk, especially those with little concern about monkeypox and those with a high level of education. Even though obtained in a Dutch context, we believe our findings may also be relevant for other countries with similar conditions.

Data availability

Study materials and raw data are available upon request.

Ethical statement

The study was assessed and approved by the ERCPN of Maastricht University (ref.188_11_02_2018_S32). Informed consent was provided by all participants.

Funding statement

There was no funding source for this study.

Acknowledgements

We thank all study participants contribute to our study.

This work was published as a preprint article on MedRxiv (Wang H, d’Abreu de Paulo K.J.I., Gültzow T, Zimmermann H.M.L, Jonas K.J. Monkeypox self-diagnosis abilities, determinants of vaccination intention and self-isolation intention after diagnosis among MSM in the Netherlands. MedRxiv. 2022 July 29).

Supplementary Data

Supplementary Materials

Conflict of interest: None declared.

Authors’ contributions: All authors conceptualised this research; KJJ collected the data for this research; HW and KJIDDP analysed the data; HW, KJIDDP, TG, HMLZ and KJJ drafted the manuscript; TG, HMZL and KJJ edited the manuscript; all authors critically revised the manuscript for intellectual content. All authors read and approved the final version of the manuscript.

References

  • 1. Bragazzi NL, Kong JD, Mahroum N, Tsigalou C, Khamisy-Farah R, Converti M, et al. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review. J Med Virol. 2022;jmv.27931. 10.1002/jmv.27931 [DOI] [PubMed] [Google Scholar]
  • 2. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141. 10.1371/journal.pntd.0010141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.European Centre for Disease Prevention and Control (ECDC). Joint ECDC-WHO Regional Office for Europe Monkeypox Surveillance Bulletin. Stockholm: ECDC; 2022. Available from: https://monkeypoxreport.ecdc.europa.eu/.
  • 4.National Institute for Public Health and the Environment (RIVM). Monkeypox. Bilthoven: RIVM; 2022. Available from: https://www.rivm.nl/en/monkeypox.
  • 5. Van Dijk M, De Wit JBF, Guadamuz TE, Martinez JE, Jonas KJ. Quality of Sex Life and Perceived Sexual Pleasure of PrEP Users in the Netherlands. J Sex Res. 2022;59(3):303-8. 10.1080/00224499.2021.1931653 [DOI] [PubMed] [Google Scholar]
  • 6.Public Health Service of Amsterdam (GGD-Amsterdam). Amsterdam start maandag 25 juli met vaccineren tegen monkeypox. Amsterdam: GGD Amsterdam; 2022. Available from: https://www.ggd.amsterdam.nl/nieuwsoverzicht/start-vaccineren-monkeypox/.
  • 7.National Institute for Public Health and the Environment (RIVM). Monkeypox (apenpokken). Bilthoven: RIVM; 2022. Available from: https://lci.rivm.nl/richtlijnen/monkeypox-apenpokken
  • 8.National Institute for Public Health and the Environment (RIVM). Monkeypox vaccination. Bilthoven: RIVM; 2022. Available from: https://www.rivm.nl/en/monkeypox/vaccination.
  • 9. Miura F, van Ewijk CE, Backer JA, Xiridou M, Franz E, Op de Coul E, et al. Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022. Euro Surveill. 2022;27(24). 10.2807/1560-7917.ES.2022.27.24.2200448 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Kupferschmidt K. Monkeypox vaccination plans take shape amid questions. Science. 2022;376(6598):1142-3. 10.1126/science.add3743 [DOI] [PubMed] [Google Scholar]
  • 11.World Health Organization (WHO). Measuring the effectiveness and impact of public health and social measures. Geneva: WHO; 2022. Available from: https://www.who.int/activities/measuring-the-effectiveness-and-impact-of-public-health-and-social-measures.
  • 12. Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. N Engl J Med. 2022;NEJMoa2207323. 10.1056/NEJMoa2207323 [DOI] [PubMed] [Google Scholar]
  • 13. Peters GJ, Ruiter RA, Kok G. Threatening communication: a critical re-analysis and a revised meta-analytic test of fear appeal theory. Health Psychol Rev. 2013;7(sup1) Suppl 1;S8-31. 10.1080/17437199.2012.703527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Riccò M, Ferraro P, Camisa V, Satta E, Zaniboni A, Ranzieri S, et al. When a Neglected Tropical Disease Goes Global: Knowledge, Attitudes and Practices of Italian Physicians towards Monkeypox, Preliminary Results. Trop Med Infect Dis. 2022;7(7):135. 10.3390/tropicalmed7070135 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Materials

Articles from Eurosurveillance are provided here courtesy of European Centre for Disease Prevention and Control

RESOURCES